Bone Marrow Protective Effect of Trilaciclib in Postoperative CCRT for LA-HNSCC
Bone Marrow Protective Effect of Trilaciclib in Postoperative CCRT for LA-HNSCC
Recruiting · NCT06752798 · Registry updated 2024-12-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Bone Marrow Protective Effect of Trilaciclib in Postoperative CCRT for LA-HNSCC | Head and Neck Neoplasms, Neoplasms by Site, neoplasm | Recruiting | Phase 2 | 2024-12-31 | NCT06752798 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hunan Cancer Hospital | 66 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hunan Cancer Hospital | Changsha | China | 41 |